Cronos Group (CRON) Competitors

C$3.99
-0.15 (-3.62%)
(As of 05/17/2024 ET)

CRON vs. WEED, TLRY, GUD, ACB, BHC, DNTL, SIA, WELL, EXE, and OGI

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Canopy Growth (WEED), Tilray Brands (TLRY), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Bausch Health Companies (BHC), dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Extendicare (EXE), and Organigram (OGI). These companies are all part of the "medical" sector.

Cronos Group vs.

Cronos Group (TSE:CRON) and Canopy Growth (TSE:WEED) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends, media sentiment and community ranking.

Canopy Growth received 571 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 62.44% of users gave Canopy Growth an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
69
50.74%
Underperform Votes
67
49.26%
Canopy GrowthOutperform Votes
640
62.44%
Underperform Votes
385
37.56%

Canopy Growth has a net margin of 0.00% compared to Cronos Group's net margin of -61.31%. Cronos Group's return on equity of -4.99% beat Canopy Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-61.31% -4.99% -4.02%
Canopy Growth N/A -121.56%-8.89%

Cronos Group has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Canopy Growth has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500.

Cronos Group currently has a consensus price target of C$3.18, suggesting a potential downside of 20.30%. Canopy Growth has a consensus price target of C$3.20, suggesting a potential downside of 78.39%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Canopy Growth
2 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Canopy Growth had 2 more articles in the media than Cronos Group. MarketBeat recorded 5 mentions for Canopy Growth and 3 mentions for Cronos Group. Canopy Growth's average media sentiment score of 0.82 beat Cronos Group's score of 0.80 indicating that Canopy Growth is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Canopy Growth
2 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

13.1% of Cronos Group shares are owned by institutional investors. Comparatively, 4.3% of Canopy Growth shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cronos Group has higher earnings, but lower revenue than Canopy Growth. Cronos Group is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$93.03M16.38-C$54.14M-C$0.19-21.00
Canopy GrowthC$362.24M3.07-C$1.18B-C$21.30-0.70

Summary

Cronos Group beats Canopy Growth on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

MetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$1.52BC$1.16BC$5.24BC$5.48B
Dividend YieldN/A2.99%44.24%5.53%
P/E Ratio-21.00519.7396.9623.46
Price / Sales16.389,729.642,362.832,193.02
Price / Cash1.6710.1336.7479.97
Price / Book1.417.345.493.21
Net Income-C$54.14MC$153.38MC$105.95MC$291.33M
7 Day Performance5.00%0.73%1.42%1.54%
1 Month Performance23.15%1.25%4.96%3.93%
1 Year Performance54.65%31.66%7.84%26.53%

Cronos Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WEED
Canopy Growth
0.0631 of 5 stars
C$12.98
-2.5%
C$3.20
-75.3%
+950.4%C$1.18BC$362.24M-0.612,700News Coverage
TLRY
Tilray Brands
0.0098 of 5 stars
C$2.73
-2.8%
C$2.95
+8.1%
-18.5%C$2.06BC$700.50M-0.881,600News Coverage
Gap Down
GUD
Knight Therapeutics
1.0648 of 5 stars
C$5.87
-0.8%
C$6.63
+13.0%
+26.8%C$593.87MC$328.20M-36.69725
ACB
Aurora Cannabis
0.0279 of 5 stars
C$9.15
+0.5%
C$2.26
-75.3%
+1,110.8%C$499.04MC$275.88M-0.121,130Gap Up
BHC
Bausch Health Companies
0.2344 of 5 stars
C$10.20
-0.7%
C$9.00
-11.8%
-20.0%C$3.73BC$8.76B-4.6420,270
DNTL
dentalcorp
2.3214 of 5 stars
C$6.25
-1.4%
C$10.72
+71.6%
-16.4%C$1.12BC$1.43B-13.599,900News Coverage
SIA
Sienna Senior Living
1.9479 of 5 stars
C$14.00
-1.1%
C$14.00
+29.5%C$1.02BC$785.37M140.0012,000Dividend Announcement
Analyst Forecast
News Coverage
Positive News
WELL
WELL Health Technologies
0.7475 of 5 stars
C$3.58
-1.9%
C$7.13
+99.0%
-15.5%C$879.36MC$776.05M-185.00392
EXE
Extendicare
0.6558 of 5 stars
C$7.43
-1.1%
C$7.88
+6.0%
+8.1%C$617.88MC$1.30B18.5823,000Dividend Announcement
Analyst Forecast
News Coverage
OGI
Organigram
3.0443 of 5 stars
C$2.51
-2.7%
C$3.85
+53.4%
+310.6%C$258.53MC$149.21M-1.00984Analyst Forecast
Analyst Revision
News Coverage
Gap Up

Related Companies and Tools

This page (TSE:CRON) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners